Company Profile
Updated: 09-SEP-09Cellzome Ag
International Private company
Meyerhofstr. 1, Heidelberg, 69117, Germany
()6221137570,
Primary SIC: Noncommercial Research Organizations, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Noncommercial Research Organizations
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Other News To Note.
BIOWORLD Today; 11/4/2009; 1842 words; ...launch in 2003, subject to regulatory approval. Apovia AG, of Martinsried, Germany, and its wholly owned subsidiary...believes is required by many directed evolution technologies. Cellzome AG, of Heidelberg, Germany, named David Brown president...
Cellzome AG-Company Report.
M2 Presswire; 1/25/2009; 493 words; ...25 January 2009-www.companiesandmarkets.com: Cellzome AG-Company Report(C)1994-2009 M2 COMMUNICATIONS...25012009 -www.companiesandmarkets.com adds new report: Cellzome AG-Company Report Private Company Reports provide up to...
WIPO: Inventors in Germany Develop Discoidin Domain Receptor 1 Positive Cancer Treatment Method
US Fed News Service, Including US State News; 12/8/2008; 380 words; ...developed a treatment of discoidin domain receptor 1 positive cancer using imatinib. The patent has been assigned to Cellzome AG, Heidelberg, Germany. According to an abstract posted by the World Intellectual Property Organization, the present...
Findings in proteomics reported from Cellzome AG.
Biotech Week; 11/26/2008; 732 words; ...M. Bantscheff and colleagues, Cellzome AG. The researchers concluded...information, contact M. Bantscheff, Cellzome AG, Meyerhofstr 1, D-69117 Heidelberg...Peptide, Proteins, Proteomics, Cellzome AG. This article was prepared by...
Final Call to Register for BioPartnering Europe (BPE).
Business Wire; 10/2/2008; 1665 words; ...ImmunoTherapeutics, BTG, Calabar AB, Celleron Therapeutics, Cellzome Inc., Cequent Pharmaceuticals, Ceregene Inc., Cerenis Therapeutics...Technologies SA, f-star Biotechnology, Ganymed Pharmaceuticals AG, Genera Biosystems Limited, Glytech, Haemostatix Ltd, Halozyme...
Recent News Articles
- Findings in proteomics reported from Cellzome AG.
Biotech Week - November 26, 2008 - 2.2 M euro R&D grant for Cellzome and Graffinity.(Graffinity Pharmaceuticals AG, Cellzome GmbH)(Brief Article)
Pharma Marketletter - October 17, 2005 - Cellzome AG Appoints Dr. David Brown as President and CEO.
PR Newswire - September 16, 2002
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning